GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (LSE:INDV) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Indivior (LSE:INDV) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Apr. 15, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Indivior Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Indivior's Future 3-5Y EPS without NRI Growth Rate is N/A.


Competitive Comparison of Indivior's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Indivior's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indivior's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indivior's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Indivior's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Indivior  (LSE:INDV) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Indivior Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Indivior's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Indivior Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (LSE:INDV) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Traded in Other Exchanges
Address
10710 Midlothian Turnpike, Suite 125, North Chesterfield, Richmond, VA, USA, 23235
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.